Ardeparin Subcutaneous and Lithium Carbonate
Determining the interaction of Ardeparin Subcutaneous and Lithium Carbonate and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ardeparin
Brand name: Baciguent, Probiotic Formula, Proferrin-ES
Synonyms: Ardeparin (Subcutaneous)
Generic Name: lithium
Brand name: Lithobid, Eskalith, Lithonate, Lithotabs, Eskalith-CR
Synonyms: Lithium
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ardeparin Subcutaneous-Lithium Carbonate ER Tablets
- Ardeparin Subcutaneous-Lithium Carbonate Tablets
- Ardeparin Subcutaneous-Lithium Citrate Syrup
- Ardeparin Subcutaneous-Lithium Controlled-Release and Extended-Release Tablets
- Ardeparin Subcutaneous-Lithium ER
- Ardeparin Subcutaneous-Lithium Oral Solution
- Lithium Carbonate-Aredia
- Lithium Carbonate-Arestin
- Lithium Carbonate-Arestin eent
- Lithium Carbonate-Arestin mucous membrane powder
- Lithium Carbonate-Arformoterol
- Lithium Carbonate-Arformoterol inhalation